Following Thomas Patrick Joyce’s last DHR Sell transaction on April 24, 2018, the stock climbed by 5.0%. In addition to Thomas Patrick Joyce, 4 other DHR executives reported Sell trades in the last month.
Based on Danaher Corp’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $4.85 billion and quarterly net profit of $664 million. In comparison, last year the company earned revenue of $4.53 billion and had a net profit of $572 million. DHR’s market cap is $73.41B and the company has a P/E ratio of 26.93. Currently, Danaher Corp has an average volume of 2.61M.
Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $118.00, reflecting a 13.0% upside.
In the last 30 days, insiders have sold $9.9M worth of DHR shares and purchased $25.53K worth of DHR shares. The insider sentiment on Danaher Corp has been negative according to 75 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.